» Articles » PMID: 35054976

A New Player in the Hippocampus: A Review on VGLUT3+ Neurons and Their Role in the Regulation of Hippocampal Activity and Behaviour

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Jan 21
PMID 35054976
Authors
Affiliations
Soon will be listed here.
Abstract

Glutamate is the most abundant excitatory amino acid in the central nervous system. Neurons using glutamate as a neurotransmitter can be characterised by vesicular glutamate transporters (VGLUTs). Among the three subtypes, VGLUT3 is unique, co-localising with other "classical" neurotransmitters, such as the inhibitory GABA. Glutamate, manipulated by VGLUT3, can modulate the packaging as well as the release of other neurotransmitters and serve as a retrograde signal through its release from the somata and dendrites. Its contribution to sensory processes (including seeing, hearing, and mechanosensation) is well characterised. However, its involvement in learning and memory can only be assumed based on its prominent hippocampal presence. Although VGLUT3-expressing neurons are detectable in the hippocampus, most of the hippocampal VGLUT3 positivity can be found on nerve terminals, presumably coming from the median raphe. This hippocampal glutamatergic network plays a pivotal role in several important processes (e.g., learning and memory, emotions, epilepsy, cardiovascular regulation). Indirect information from anatomical studies and KO mice strains suggests the contribution of local VGLUT3-positive hippocampal neurons as well as afferentations in these events. However, further studies making use of more specific tools (e.g., Cre-mice, opto- and chemogenetics) are needed to confirm these assumptions.

Citing Articles

Deciphering the Functions of Raphe-Hippocampal Serotonergic and Glutamatergic Circuits and Their Deficits in Alzheimer's Disease.

Yu W, Zhang R, Zhang A, Mei Y Int J Mol Sci. 2025; 26(3).

PMID: 39941002 PMC: 11818420. DOI: 10.3390/ijms26031234.


μ-Opioid Receptor Modulation of the Glutamatergic/GABAergic Midbrain Inputs to the Mouse Dorsal Hippocampus.

Kim H, Dey S, Sekerkova G, Martina M J Neurosci. 2024; 44(43).

PMID: 39251354 PMC: 11502231. DOI: 10.1523/JNEUROSCI.0653-24.2024.


The multitaskers of the brain: Glial responses to viral infections and associated post-infectious neurologic sequelae.

Dave V, Klein R Glia. 2022; 71(4):803-818.

PMID: 36334073 PMC: 9931640. DOI: 10.1002/glia.24294.

References
1.
Senft R, Freret M, Sturrock N, Dymecki S . Neurochemically and Hodologically Distinct Ascending VGLUT3 versus Serotonin Subsystems Comprise the r2- Median Raphe. J Neurosci. 2021; 41(12):2581-2600. PMC: 8018730. DOI: 10.1523/JNEUROSCI.1667-20.2021. View

2.
Pelkey K, Calvigioni D, Fang C, Vargish G, Ekins T, Auville K . Paradoxical network excitation by glutamate release from VGluT3 GABAergic interneurons. Elife. 2020; 9. PMC: 7039679. DOI: 10.7554/eLife.51996. View

3.
Kudo T, Uchigashima M, Miyazaki T, Konno K, Yamasaki M, Yanagawa Y . Three types of neurochemical projection from the bed nucleus of the stria terminalis to the ventral tegmental area in adult mice. J Neurosci. 2012; 32(50):18035-46. PMC: 6621739. DOI: 10.1523/JNEUROSCI.4057-12.2012. View

4.
Schmidt-Supprian M, Rajewsky K . Vagaries of conditional gene targeting. Nat Immunol. 2007; 8(7):665-8. DOI: 10.1038/ni0707-665. View

5.
Campbell E, Marchant N . The use of chemogenetics in behavioural neuroscience: receptor variants, targeting approaches and caveats. Br J Pharmacol. 2018; 175(7):994-1003. PMC: 5843707. DOI: 10.1111/bph.14146. View